Observational studyBMC infectious diseases2026
Longitudinal observation of persistent Long COVID symptoms and health-related quality of life in an adult German cohort.
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany individuals experience persistent symptoms following an acute COVID-19 infection, a condition known as Long COVID. The aim of this study was to analyse the prevalence, intensity and longitudinal trajectories of different Long COVID symptoms at baseline and at follow-ups up to 60 weeks later in a German cohort.
methodsThis longitudinal observational study is part of the DEFEAT Corona project, wherein Long COVID subjects completed online questionnaires on symptom severity (0-10 points) and health-related quality of life (hrQoL), measured with EQ5D-VAS, at three time points. At baseline, sociodemographic information, COVID-19 infection characteristics, and COVID-19 vaccination status were also recorded. Symptom occurrence and intensity was compared between baseline and two follow-up surveys 54 to 60 weeks later.
resultsAmong n = 262 adult participants (84.4% female, 14.8% male and 0.8% diverse, mean age 44.85 ± 11.48 years), the most frequent symptoms at baseline were fatigue (67.2%, mean severity 9.02 ± 0.89), palpitations (61.1%, mean severity 6.58 ± 1.95), and concentration impairment (61.0%, mean severity 8.55 ± 1.12). The prevalence decreased in 3/27 Long COVID symptoms and symptom intensity decreased in 15/27 symptoms with small changes in severity (between 0.6 and 2 points of max. 10 points). HrQoL decreased significantly over time (p = 0.006). However, the mean change of - 4.31 ± 21.2 points remained below the established MCID of 7.5 points, indicating no clinically meaningful deterioration.
conclusionMore than a year after the acute infection, Long COVID patients of the DEFEAT Corona cohort describe symptoms as persistent and intense. With the corresponding impairment in hrQoL, this underlines the urgent need for comprehensive therapies for Long COVID.
trial registrationThe study was in the German Clinical Trial Registry (DRKS00026007) on 9th Sep 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.